Neurotrophic and Neuroprotective Actions of (−)- and (+)-Phenserine, Candidate Drugs for Alzheimer’s Disease

@inproceedings{Lilja2013NeurotrophicAN,
  title={Neurotrophic and Neuroprotective Actions of (−)- and (+)-Phenserine, Candidate Drugs for Alzheimer’s Disease},
  author={Anna M. Lilja and Y. X. Luo and Qian-sheng Yu and Jennie R{\"o}jdner and Yazhou Li and Ann M. Marini and Amelia Marutle and A. Nordberg and Nigel H. Greig},
  booktitle={PloS one},
  year={2013}
}
Neuronal dysfunction and demise together with a reduction in neurogenesis are cardinal features of Alzheimer's disease (AD) induced by a combination of oxidative stress, toxic amyloid-β peptide (Aβ) and a loss of trophic factor support. Amelioration of these was assessed with the Aβ lowering AD experimental drugs (+)-phenserine and (-)-phenserine in neuronal cultures, and actions in mice were evaluated with (+)-phenserine. Both experimental drugs together with the metabolite N1-norphenserine… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 59 references

Brain-derived neurotrophic factor and neuropsychiatric disorders.

Pharmacological reviews • 2012
View 15 Excerpts
Highly Influenced

Glutamate and neurotrophic factors in neuronal plasticity and disease.

Annals of the New York Academy of Sciences • 2008
View 13 Excerpts
Highly Influenced

Fire in the ashes: can failed Alzheimer's disease drugs succeed with second chances?

Alzheimer's & dementia : the journal of the Alzheimer's Association • 2013
View 1 Excerpt

2012 Alzheimer ’ s disease facts and figures

W Thies, L Bleiler
Alzheimers Dement • 2012

Similar Papers

Loading similar papers…